Overview

Use of Minocicline in Patients With Stroke

Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The investigators will evaluate the National Institute of Health Stroke Scale/Score (NIHSS)in patients with stroke, and then give Minocycline 100mg po every 12 hours or placebo for five days, then perform periodic evaluations to determine the status and degree of neurological sequelae developed.
Phase:
Phase 1
Details
Lead Sponsor:
Hospital Universitario Hernando Moncaleano Perdomo